Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Tolerability of Buspirone for the Treatment of Anxiety in Parkinson's Disease

NCT02803749 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT02803749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02803749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Tolerability of Buspirone for the Treatment of Anxiety in Parkinson's Disease
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2016
Completion date
January 25, 2019
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, parkinson disease